Treatment and management of cognitive dysfunction in patients with multiple sclerosis

被引:0
|
作者
John DeLuca
Nancy D. Chiaravalloti
Brian M. Sandroff
机构
[1] Kessler Foundation,Department of Physical Therapy
[2] University of Alabama at Birmingham,undefined
来源
Nature Reviews Neurology | 2020年 / 16卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cognitive impairment is a common and devastating manifestation of multiple sclerosis (MS). Although disease-modifying therapies have been efficacious for reducing relapse rates in MS, such treatments are ineffective for treating cognitive dysfunction. Alternative treatment approaches for mitigating cognitive problems are greatly needed in this population. To date, cognitive rehabilitation and exercise training have been identified as possible candidates for treating MS-related cognitive impairment; however, cognitive dysfunction is still often considered to be poorly managed in patients with MS. This Review provides a comprehensive overview of recent developments in the treatment and management of cognitive impairment in people with MS. We describe the theoretical rationales, current states of the science, field-wide challenges and recent advances in cognitive rehabilitation and exercise training for treating MS-related cognitive impairment. We also discuss future directions for research into the treatment of cognitive impairment in MS that should set the stage for the inclusion of cognitive rehabilitation and exercise training into clinical practice within the next decade.
引用
收藏
页码:319 / 332
页数:13
相关论文
共 50 条
  • [1] Treatment and management of cognitive dysfunction in patients with multiple sclerosis
    DeLuca, John
    Chiaravalloti, Nancy D.
    Sandroff, Brian M.
    NATURE REVIEWS NEUROLOGY, 2020, 16 (06) : 319 - 332
  • [2] An update on the treatment and management of cognitive dysfunction in patients with multiple sclerosis
    De Meo, Ermelinda
    Portaccio, Emilio
    Bonacchi, Raffaello
    Giovannoli, Jasmine
    Niccolai, Claudia
    Amato, Maria Pia
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2025, 25 (02) : 227 - 243
  • [3] Cognitive Dysfunction in Treatment-naive Patients with Multiple Sclerosis
    Botchorishvili, N.
    Dzagnidze, A.
    Mikava, N.
    Mikeladze, N.
    Tighashvili, M.
    Janelidze, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 199 - 199
  • [4] Risk factors for and management of cognitive dysfunction in multiple sclerosis
    Benedict, Ralph H. B.
    Zivadinov, Robert
    NATURE REVIEWS NEUROLOGY, 2011, 7 (06) : 332 - 342
  • [5] Risk factors for and management of cognitive dysfunction in multiple sclerosis
    Ralph H. B. Benedict
    Robert Zivadinov
    Nature Reviews Neurology, 2011, 7 : 332 - 342
  • [6] Management of Urinary Dysfunction in Patients with Multiple Sclerosis
    Lipan, Camelia G.
    Mischianu, Dan
    Voda, Vlad I.
    Amza, Radu A.
    Sirbu, Carmen A.
    Antochi, Florina A.
    Roceanu, Adina M.
    ROMANIAN JOURNAL OF MILITARY MEDICINE, 2024, 127 (03)
  • [7] Evaluation of the determinants of cognitive dysfunction in patients with multiple sclerosis
    Alireza Haji Seyed Javadi
    Ali Akbar Shafikhani
    Neda Beizapour
    Middle East Current Psychiatry, 29
  • [8] Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis
    Shumita Roy
    Ralph H. B. Benedict
    Allison S. Drake
    Bianca Weinstock-Guttman
    CNS Drugs, 2016, 30 : 209 - 225
  • [9] Evaluation of the determinants of cognitive dysfunction in patients with multiple sclerosis
    Javadi, Alireza Haji Seyed
    Shafikhani, Ali Akbar
    Beizapour, Neda
    MIDDLE EAST CURRENT PSYCHIATRY-MECPSYCH, 2022, 29 (01):
  • [10] Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis
    Roy, Shumita
    Benedict, Ralph H. B.
    Drake, Allison S.
    Weinstock-Guttman, Bianca
    CNS DRUGS, 2016, 30 (03) : 209 - 225